Sinofn Health Sinofn Health

Global Bio-Nutrient Supply Chain Integration

Raw Material Manufacturer & Factory serving the Timor-Leste market

Industrial Landscape & Health Challenges in Timor-Leste

Navigating the Transition from Basic Healthcare to Advanced Functional Nutrition

Timor-Leste, one of the youngest sovereign nations in the world, is undergoing a critical transition in its public health and socio-economic frameworks. As the Ministry of Health (Ministério da Saúde) and international organizations like the WHO and UNICEF ramp up efforts to combat persistent malnutrition, maternal anemia, and child development deficits, the demand for highly stable, nutrient-dense, and therapeutically viable raw materials has surged. Historically, the nation relied heavily on imported, low-nutrient staple foods, which contributed to a high prevalence of stunting in rural municipalities such as Ermera, Ainaro, and Oecusse.

Our mandate as a global raw material manufacturer serving Timor-Leste is to supply active pharmaceutical and food-grade ingredients that withstand the country’s high relative humidity and average temperatures exceeding 30°C. By introducing stabilized ingredients—such as cyclical adenosine monophosphate (cAMP) rich jujube extracts and highly soluble polysaccharide complexes—we empower local health departments, NGOs, and growing pharmaceutical enterprises to formulate target-specific supplements that do not degrade during transit or warehousing in tropical conditions.

Critical Need: Nutritional Fortification in Sub-Tropical Ecosystems

The tropical maritime climate of Timor-Leste presents severe challenges to the stability of vitamins, amino acids, and active enzymes. Standard powdered formulations tend to hygroscopically degrade, losing up to 40% of their bio-efficacy within three months of storage in non-temperature-controlled logistics nodes. SINOFN utilizes advanced micro-encapsulation and specialized freeze-drying technologies that shield functional biomolecules, ensuring maximum stability from our GMP facilities to Dili Port and onwards to regional clinics.

Emerging Trends in APAC Raw Material Procurement

Decentralized Supply Chains, Non-GMO Certification, and Science-Backed Bio-actives

The global pharmaceutical and dietary supplement industries are shifting rapidly toward transparency, clinical validation, and vertical integration. Procurement officers for pharmaceutical brands across the Asia-Pacific region, including those managing imports into Timor-Leste, now prioritize clean-label raw materials backed by peer-reviewed clinical research. As the regulatory body SAMES (Serviço Autónomo de Medicamentos e Equipamentos de Saúde) tightens control over therapeutic imports to protect the Timorese population, raw material suppliers must demonstrate rigorous quality certifications, such as HACCP, ISO 22000, and Halal.

Furthermore, there is a global push toward plant-derived cyclic nucleotides and therapeutic macro-fungi polysaccharides. Synthetic alternatives are increasingly rejected in favor of biomimetic ingredients extracted via green chemistry methodologies. Our collaboration with the Chinese Academy of Sciences places SINOFN at the forefront of this trend, developing standardized botanical extractions that deliver consistent bioactive yields without harmful solvent residues.

53,000㎡
State-of-the-Art Factory Footprint
350M+
RMB Capitalized R&D Investment
36
Patented Bioactive Technologies
71+
Registered Global Trademarks

About SINOFN

Science-Driven OEM/ODM for Global Supplement Brands

SINOFN Health Co., Ltd. is the dedicated supplement OEM/ODM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the global trading and logistics hub for international partners seeking premium, science-driven contract manufacturing services and active raw materials.

SINOFN R&D Infrastructure SINOFN State of Art Production

Our Founder: GuoHong Liu

A Legacy Built on Special Medical Foods & Ethical Access

During her clinical work, Mrs. Liu witnessed the lifelong struggles of PKU (Phenylketonuria) children – where specialized medical diets were financially out of reach for average families. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods and specialized medical ingredients.

Her commitment to accessibility attracted strategic national investors and fueled transformative growth, leading to key achievements:

  • From PKU to Global Health: Expanded formulation scope into FSMP (Foods for Special Medical Purposes), clinical nutrition, and active nutraceutical raw materials.
  • Profit with Purpose: Allocates dedicated revenues directly to international PKU food accessibility initiatives.
  • R&D Legacy: Established the world-class Tianjin Research & Development Center in partnership with the Chinese Academy of Sciences (CAS).

"We measure success not just in raw manufacturing capacity, but in lives improved through globally accessible science." – Mrs. GuoHong Liu, Founder

GuoHong Liu Founder of SINOFN

Leading Scientific Advisory Board & R&D Team

Building excellent product quality through rigorous academic cooperation and specialized medical insight

Through strategic cooperation with top global universities and internal talent development, SINOFN has established an elite research and development team. Led by clinical experts from Peking University and the Chinese Academy of Sciences, we focus on bioactive isolation, compound stability validation, and next-generation delivery tech.
Dr. Tan Shengjie Medical Innovation Director
Dr. Tan Shengjie
Medical Innovation Director
Ph.D. from Peking University Medical School. Over 15 years of specialization in metabolic disorder formulations, FSMP pathways, and clinical trial supervision.
Dr. Zhang Ying R&D Lead
Dr. Zhang Ying
R&D Team Lead
Associate Researcher, CAS Postdoctoral Fellow. Internationally published expert in targeted bioactive delivery systems and micro-encapsulation structural kinetics.
Hans van Dijk Formulation Director
Hans van Dijk
Formulation Director
Senior Scientist from the Netherlands. Expert in European Food Safety Authority (EFSA) regulations, special dietary food industrialization, and bioavailability optimization.

Macro-Industry Raw Material Solutions for Timor-Leste

Establishing Resilient Bioactive Supply Chains from Shanghai to Dili and Tibar Bay Port

Developing functional foods and clinical pharmaceuticals in Timor-Leste requires resolving multiple logistical and regulatory bottlenecks. Standard bulk powder imports often suffer from extended customs clearance, lack of proper local testing facilities, and temperature shocks during equatorial shipping routes. To solve this, SINOFN has developed a dedicated Indo-Pacific supply corridor, optimizing transit times through key transshipment hubs like Singapore and Surabaya direct to the newly operational Tibar Bay Port.

Moreover, we provide full technical dossier support for SAMES and the Ministry of Health approvals, ensuring that every batch of active pharmaceutical ingredients (APIs), vitamins, and herbal concentrates matches international pharmacopoeia standards. Our technical services team offers step-by-step assistance to local formulators in Dili, helping them incorporate specialized ingredients like β‑Nicotinamide Mononucleotide (NMN) and high-purity PQQ into liquid elixirs and stable capsule matrices adapted for the regional demographic.

Our Factory Capabilities & Testing Centers

Rigorous quality control processes driving clean-label, bioavailable output

GMP Production Lines
GMP Production Lines
10+ dedicated automated lines for softgels, gummies, and powders. ISO 22000, HACCP, FSSC 22000 certified. Annual capacity: 500M+ units.
Inquire Capacity →
QA & Testing Center
QA & Testing Center
Equipped with HPLC/GC-MS for contaminant screening, heavy metal limits testing, microbiological safety, and active ingredient stability validation.
View QC Protocols →
R&D Center
R&D Pilot Center
Pilot-scale prototyping for custom capsules, liquid formulations, and tablets. Specializes in bioavailability and dissolution time optimizations.
Request Prototype →
Full-Plant Integration
Full-Plant Integration
Integrated raw material storage, cleanroom production, and packaging. Blockchain-enabled batch tracking for seamless product recall protection.
Track Batch History →

Technical Roadmap & Future Outlook

Advancing Cellular Longevity and Targeted Metabolic Therapies for Developing Markets

Looking ahead, SINOFN is positioning its research development toward clinical applications of enzyme-catalyzed β-Nicotinamide Mononucleotide (NMN) and structural variations of PQQ. These compounds, historically classified as high-cost luxury nutrients, are being re-engineered at our facilities for cost-effective mass production. This development aligns directly with our mission to supply affordable, high-efficacy functional ingredients to emerging economies like Timor-Leste, where population aging and lifestyle metabolic issues are increasingly prevalent.

Additionally, we are expanding research into customized formulations for Phenylketonuria (PKU) and other genetic metabolic disorders, working closely with pediatric researchers in Europe and Asia. By combining natural plant extracts with precise amino acid profiles, our formulation engineers aim to supply the next generation of Foods for Special Medical Purposes (FSMP) that are highly palatable, nutrient-dense, and stable under extreme climatic conditions without artificial preservatives.

Strategic Partnership: Chinese Academy of Sciences (CAS)

Our ongoing collaborative research with the CAS ensures that SINOFN remains at the absolute cutting edge of extraction technologies. We are presently mapping out the metabolic pathways of cyclic nucleotides to optimize energy conversion at the cellular level, offering raw materials with verified bio-absorbability rates up to 30% higher than industry benchmarks.

Active Ingredient Catalog & Raw Materials for Timor-Leste

Select from our certified range of functional raw materials. Standardized, stable, and ready for commercial formulation.

Specialized Medical Dietary Supplements & Formulations

International Certifications & IP Integrity

Demonstrating complete reliability through rigorous licensing, software copyrights, and international safety audits

SINOFN prioritizes intellectual property and consumer safety above all. We hold 36 registered patents (including 11 invention patents, 12 utility model patents, 11 software copyrights, and 2 design patents) and 71 multi-category trademarks globally. Our manufacturing processes are audited and fully certified under ISO 9001, ISO 22000, HACCP, and HALAL, ensuring that every consignment sent to Timor-Leste meets stringent quality standards.
HACCP Certified SINOFN Raw Materials
ISO 9001 Quality Management Certificate
Halal certified active ingredients
ISO 22000 Food Safety Standards
FDA and global safety compliance audits

Frequently Asked Questions (FAQ)

Technical and regulatory insights on raw material procurement for the Timor-Leste market

How do you guarantee the chemical stability of raw materials shipped to Dili Port?

To prevent raw materials from degrading under Timor-Leste's high relative humidity and tropical temperatures, we utilize double-layered vacuum barriers, nitrogen flushing, and moisture-impermeable aluminum-foil drum liners. For highly sensitive compounds like cAMP Jujube extract and Vitamin C supplements, we apply advanced micro-encapsulation techniques that shield the active biomolecules. Additionally, our logistics team coordinates temperature-monitored shipping routes to ensure consistency upon arrival.

Can you assist local pharmaceutical and food companies with SAMES import approvals?

Yes. We provide complete technical dossiers including Certificates of Analysis (COA), heavy metal and microbiological screening reports, stability data validation, and GMP manufacturing documentation. These dossiers are structured to align directly with SAMES (Serviço Autónomo de Medicamentos e Equipamentos de Saúde) and the Timor-Leste Ministry of Health regulatory standards, facilitating a smooth customs clearance and compliance process.

What are the minimum order quantities (MOQ) and lead times for shipments?

Our standard MOQs vary depending on the specific raw material type: bulk herbal powders start at 25 kg, while highly specialized ingredients like NMN or PQQ are available in smaller pilot-scale quantities. Average shipping lead time from our Shanghai logistics hub to Dili Port or Tibar Bay Port is 21 to 30 days, including custom clearance preparation and international transit scheduling.

Do you support customized R&D formulations for local health initiatives?

Absolutely. Backed by the Chinese Academy of Sciences and led by our Formulation Director, Hans van Dijk, we partner with regional healthcare groups, governments, and NGOs to develop custom-formulated supplements, FSMP dietary powders (like PKU foods), and micronutrient-fortified drink mixes specifically target-focused to combat local health challenges like childhood stunting.

Where are your manufacturing and QA facilities located?

Our central state-of-the-art production facilities, encompassing over 53,000 square meters, are located in China, with dedicated logistics, export offices, and pilot-scale prototyping hubs based in Shanghai. All facilities operate in strict accordance with international GMP, ISO, and FDA-audited standards, allowing us to serve global markets seamlessly.

Accelerate Your Supplement Brand in Timor-Leste

Partner with SINOFN for clinical-grade raw materials, advanced stabilization technology, and comprehensive regulatory approval support.

* We reply to all technical inquiries, sample requests, and wholesale quotes within 12 business hours.